AbbVie Inc.【ABBV】Income statement

Market cap

$395.6B

P/E ratio

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	18,790	19,960	22,859	25,638	28,216	32,753	33,266	45,804	56,197	58,054	54,318	56,334
Revenue growth (%)	-
Cost of revenue	4,581	4,426	4,500	5,833	7,040	7,718	7,439	15,387	17,446	17,414	20,415	16,904
Selling, general & administrative	5,352	7,724	6,387	5,855	6,275	7,399	6,942	11,299	12,349	15,260	12,872	14,752
Operating margin (%)
Operating expenses	13,126	16,549	15,322	16,254	18,624	26,370	20,283	34,441	38,273	39,937	41,561	47,197
Operating income	5,664	3,411	7,537	9,384	9,592	6,383	12,983	11,363	17,924	18,117	12,757	9,137
Income before tax	5,332	2,369	6,645	7,884	7,727	5,197	8,426	3,398	12,989	13,477	6,250	3,716
Pretax margin (%)	28.4	11.9	29.1	30.8	27.4	15.9	25.3	7.4	23.1	23.2	11.5	6.6
Provision for income taxes	1,204	595	1,501	1,931	2,418	-490	544	-1,224	1,440	1,632	1,377	-570
Effective tax rate (%)
Net income	-	-	-	5,953	5,309	5,687	7,882	4,622	11,549	11,845	4,873	4,286
Net income margin (%)	-	-	-
Earnings per share	2.58	1.11	3.15	3.65	3.31	3.67	5.3	2.73	6.48	6.65	2.73	2.4
Diluted EPS	2.56	1.1	3.13	3.63	3.3	3.66	5.28	2.72	6.45	6.63	2.72	2.39
Dividend payout ratio (%)
Dividend per share	2	1.75	2.1	2.35	2.63	3.95	4.39	4.84	5.31	5.71	5.99	6.29